Williamson Legacy Group LLC Has $705,000 Stock Holdings in Encompass Health Co. (NYSE:EHC)

Williamson Legacy Group LLC increased its holdings in shares of Encompass Health Co. (NYSE:EHC) by 6.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 7,639 shares of the company’s stock after acquiring an additional 470 shares during the quarter. Williamson Legacy Group LLC’s holdings in Encompass Health were worth $705,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. State Street Corp lifted its position in shares of Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after purchasing an additional 21,329 shares during the last quarter. Geode Capital Management LLC raised its holdings in Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Copeland Capital Management LLC raised its holdings in Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after acquiring an additional 8,548 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in Encompass Health by 0.4% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock valued at $71,083,000 after acquiring an additional 2,904 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent research reports. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, KeyCorp upped their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Ten research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Down 0.2 %

NYSE EHC opened at $100.11 on Friday. The firm has a market cap of $10.09 billion, a PE ratio of 22.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. Encompass Health Co. has a one year low of $73.68 and a one year high of $104.55. The stock’s 50 day simple moving average is $96.42 and its 200 day simple moving average is $96.29. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.10% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.